StockData
Medline Inc. logo

Medline Inc. (MDLN) stock

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3063% above fair value
$37.84−1.32 (-3.37%)

Close on Nov 19, 2026Market cap $49.75BP/E –Yield –

Medline gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Medline's gross profit for the twelve months ending Sep 26, 2026 was $7.90B. For fiscal 2025 it was $7.52B, up 7.8% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.52B+7.8%
FY2024Dec 31, 2024$6.98B+18.5%
FY2023Dec 31, 2023$5.89B–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 26, 2026$1.93B+2.7%
Q2 FY2026Jun 27, 2026$2.22B+16.3%
Q1 FY2026Mar 28, 2026$1.84B+0.9%
Q4 FY2025Dec 31, 2025$1.91B–
Q3 FY2025Sep 27, 2025$1.88B–
Q2 FY2025Jun 28, 2025$1.91B–
Q1 FY2025Mar 29, 2025$1.82B–

More Medline figures

See a number that looks wrong?